Metacon AB's wholly owned Greek subsidiary, Metacon S.A., has been awarded European Union project funding to develop and demonstrate hydrogen production from biomethane under the BIOH2VAP project. The grant covers approximately €241,920 of the subsidiary's €302,400 project budget.
The project is intended to validate Metacon's reforming technology in an industrial biogas setting and to assess the commercial potential of converting locally produced biomethane into renewable hydrogen.
As part of the work, a pilot plant will be constructed at an existing industrial biogas plant in Ierapetra, Crete. The facility is expected to cover biogas upgrading, biomethane production and demonstration of reforming-based hydrogen generation. Operation and data collection under industrial conditions are meant to allow Metacon to evaluate and refine technical performance and operating efficiency, and to prepare for commercial deployment.
Metacon said the project adds to the commercialization roadmap for its proprietary reforming technology and supports the development of hydrogen solutions that use renewable feedstocks. The initiative is also designed as a platform for assessing how hydrogen production can be integrated with existing biogas infrastructure and local residue streams. The stated aim is to improve resource efficiency and strengthen the business case for circular hydrogen production.
Christer Wikner, president and CEO of Metacon, said the BIOH2VAP project gives the company a new industrial platform to demonstrate clean hydrogen production from biomethane and optimize its commercial potential. He added that it expands Metacon's industrial testing base for reforming technology and supports commercialization plans targeting future deployment at existing international sites where biogas infrastructure and local renewables are already available.